Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Niraparib in Tumors Metastatic to the CNS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04992013
Recruitment Status : Not yet recruiting
First Posted : August 5, 2021
Last Update Posted : August 5, 2021
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Priscilla Brastianos, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 1, 2024
Estimated Study Completion Date : December 1, 2026